Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial

被引：15
作者：
Sanchez, Jorge [1 ,4 ]
Garcia, Elizabeth [2 ]
Lopez, Juan-Felipe [1 ]
Calle, Ana [1 ]
Buendia, Jefferson-Antonio [3 ]
机构：
[1] Univ Antioquia, Hosp Alma Mater Antioquia, Grp Clin & Expt Allergy GACE, Medellin, Colombia
[2] Surg Med Unit Otorhinolaryngol UNIMEQ ORL, Bogota, Colombia
[3] Univ Antioquia, Sch Med, Dept Pharmacol & Toxicol, Res Grp Pharmacol & Toxicol INFARTO, Medellin, Colombia
[4] Univ Antioquia, Allergol Dept, Cra 27 37 B Sur 69, Medellin, Colombia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 07期
关键词：
ASPIRIN DESENSITIZATION; NASAL POLYPOSIS; CHRONIC RHINOSINUSITIS; OMALIZUMAB TREATMENT; ASTHMA; EFFICACY; SAFETY; METAANALYSIS; PREVALENCE; IMPACT;
D O I：
10.1016/j.jaip.2023.04.033
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
after 6 months of each biological therapy (intragroup comparisons). As exploratory outcomes, we compared NSAID tolerance between biological therapies (intergroup RESULTS: A total of 38 subjects were included; 9 received omalizumab. There was an increase in the concentration needed to produce a reaction during ASA-OCT with omalizumab (P < .001) and dupilumab (P 1/4 .004) but not with mepolizumab and frequency of NSAID tolerance (omalizumab 60%, dupilumab increased ASA tolerance, whereas mepolizumab and benralizu
引用
收藏
页码：2172 / 2179
页数：8
相关论文
共 48 条
  • [1] Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
    Bachert, Claus
    Han, Joseph K.
    Desrosiers, Martin Y.
    Gevaert, Philippe
    Heffler, Enrico
    Hopkins, Claire
    Tversky, Jody R.
    Barker, Peter
    Cohen, David
    Emson, Claire
    Martin, Ubaldo J.
    Shih, Vivian H.
    Necander, Sofia
    Kreindler, James L.
    Jison, Maria
    Werkstrom, Viktoria
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (04) : 1309 - +
  • [2] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
    Bachert, Claus
    Han, Joseph K.
    Desrosiers, Martin
    Hellings, Peter W.
    Amin, Nikhil
    Lee, Stella E.
    Mullol, Joaquim
    Greos, Leon S.
    Bosso, John V.
    Laidlaw, Tanya M.
    Cervin, Anders U.
    Maspero, Jorge F.
    Hopkins, Claire
    Olze, Heidi
    Canonica, G. Walter
    Paggiaro, Pierluigi
    Cho, Seong H.
    Fokkens, Wytske J.
    Fujieda, Shigeharu
    Zhang, Mei
    Lu, Xin
    Fan, Chunpeng
    Draikiwicz, Steven
    Kamat, Siddhesh A.
    Khan, Asif
    Pirozzi, Gianluca
    Patel, Naimish
    Graham, Neil M. H.
    Ruddy, Marcella
    Staudinger, Heribert
    Weinreich, David
    Stahl, Neil
    Yancopoulos, George D.
    Mannent, Leda P.
    [J]. LANCET, 2019, 394 (10209) : 1638 - 1650
  • [3] Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
    Barroso, B.
    Valverde-Monge, M.
    Alobid, I
    Olaguibel, J. M.
    Rial, M. J.
    Quirce, S.
    Arismendi, E.
    Barranco, P.
    Betancor, D.
    Bobolea, I
    Cardaba, B.
    Carmona, Cruz M. J.
    Curto, E.
    Dominguez-Ortega, J.
    Gonzalez-Barcala, F.
    Martinez-Rivera, C.
    Mahillo-Fernandez, I
    Munoz, X.
    Picado, C.
    Plaza, V
    Munoz, Rodrigo J. M.
    Soto-Retes, L.
    Valero, A.
    del Pozo, V
    Mullol, J.
    Sastre, J.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (01) : 37 - 44
  • [4] Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
    Bavaro, Nicole
    Gakpo, Deborah
    Mittal, Anisha
    Bensko, Jillian C.
    Laidlaw, Tanya M.
    Buchheit, Kathleen M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07) : 2910 - +
  • [5] Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab
    Bertlich, Mattis
    Ihler, Friedrich
    Bertlich, Ines
    Weiss, Bernhard G.
    Groeger, Moritz
    Haubner, Frank
    [J]. MEDICINE, 2021, 100 (40) : E27471
  • [6] NSAID-induced reactions: classification, prevalence, impact, and management strategies
    Blanca-Lopez, Natalia
    Soriano, Victor
    Garcia-Martin, Elena
    Canto, Gabriela
    Blanca, Miguel
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 : 217 - 233
  • [7] Bobolea I, 2010, J INVEST ALLERG CLIN, V20, P448
  • [8] Omalizumab treatment in Samter's triad: case series and review of the literature
    Cameli, P.
    Perruzza, M.
    Salvini, M.
    Fui, A.
    Cekorja, B.
    Refini, R. M.
    Sestini, P.
    Bargagli, E.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (18) : 8124 - 8129
  • [9] Aspirin challenge and desensitization: how, when and why
    Cortellini, Gabriele
    Caruso, Cristiano
    Romano, Antonino
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 17 (04) : 247 - 254
  • [10] Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs
    Dona, Inmaculada
    Salas, Maria
    Perkins, James R.
    Barrionuevo, Esther
    Gaeta, Francesco
    Cornejo-Garcia, Jose A.
    Campo, Paloma
    Jose Torres, Maria
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (45) : 6784 - 6802
12345